| Literature DB >> 25945104 |
Dulce Carolina Almonte-Flores1, Norma Paniagua-Castro2, Gerardo Escalona-Cardoso2, Martha Rosales-Castro1.
Abstract
Evaluation of the phenolic compounds and antioxidant activity of Cedrela odorata L. and Juglans regia L. bark extracts was performed in vitro. Juglans regia showed greater extract concentration and higher antioxidant activity. Hypoglycemic activity in rats was assessed by generating a glucose tolerance curve and determining the area under the curve (AUC). Diabetes was later induced by an injection with streptozotocin (65 mg/kg of b.w.) and confirmed after 24 hours. The extract was administered (200 mg/kg b.w.) over 10 days, and blood glucose was monitored and compared with a control group. The glucose AUC showed a hypoglycemic effect of J. regia and C. odorata in normal rats. Both extracts reduced hepatic lipid peroxidation in diabetic rats. Polyphenolic extracts reduced cholesterol levels in a hypercholesterolemic mouse model and decreased hepatic lipid peroxidation. Polyphenolic extract doses of 100 and 200 mg/kg b.w. were administered alone or with cyclophosphamide (CPA) 50 mg/kg ip, which was used as a positive control. Analyses were performed using leukocytes in a comet assay after 4 and 24 h of treatment. Genotoxic effects were evaluated by the comet assay, which showed that while J. regia extract had no effect, C. odorata extract induced slight damage at 200 mg/kg, with the formation of type 0 and 1 comets.Entities:
Year: 2015 PMID: 25945104 PMCID: PMC4402197 DOI: 10.1155/2015/187346
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Concentration of phenolic compounds and antioxidant capacity in C. odorata and J. regia bark extracts.
| Solvent | Yield % | TP | TF | PAC | DPPH (EC50) |
|
|---|---|---|---|---|---|---|
|
| ||||||
| Water | 5.07 | 203.2 ± 18.0a | 94.3 ± 10.3a | 144.6 ± 16.1a | 1385.4 ± 31.8a | 7.1 ± 0.5a |
| Ethanol 96% | 2.28 | 332.4 ± 10.9b | 144.3 ± 10.3b | 180.0 ± 9.1ab | 645.5 ± 22.0b | 9.5 ± 0.5b |
| Ethanol 70% | 5.89 | 549.6 ± 20.7c | 144.6 ± 10.5b | 266.7 ± 10.7c | 654.2 ± 21.9b | 10.4 ± 0.3c |
| Ethyl acetate | 1.30 | 304.9 ± 12.1d | 186.4 ± 19.7c | 313.2 ± 11.3c | 739.1 ± 54.4c | 9.5 ± 0.5b |
|
| ||||||
| Water | 21.40 | 405.7 ± 23.0e | 257.4 ± 17.0d | 198.7 ± 2.7b | 517.7 ± 12.2d | 14.0 ± 3.8d |
| Ethanol 96% | 6.76 | 577.3 ± 24.9c | 296.5 ± 10.0e | 538.9 ± 72.6d | 323.2 ± 4.0e | 13.4 ± 1.4d |
| Ethanol 70% | 10.54 | 570.3 ± 13.4c | 321.2 ± 15.8e | 548.7 ± 59.0d | 373.8 ± 4.9e | 12.5 ± 0.9e |
| Ethyl acetate | 1.05 | 568.7 ± 15.3c | 374.8 ± 7.6f | 443.0 ± 24.0e | 331.2 ± 4.7e | 14.1 ± 1.0d |
Each value represents the mean of n = 4 ± standard deviation. Different letters between groups in each column indicate a significant difference (P < 0.05) assessed using the Fisher-LSD test.
Figure 1Glucose tolerance test in rats. (a) Glucose levels. (b) Area under the glucose curve. Two-way RM ANOVA for (a) and one-way ANOVA for (b). ∗ P < 0.05, significant difference compared with the control group.
Blood glucose levels during the study period (10 days) in Wistar rats.
| Group | Blood glucose (mg/dL) | |||
|---|---|---|---|---|
| Day 1 | Day 2 | Day 3 | Day 10 | |
| Control | 90.6 ± 17.0a | 95.4 ± 5.5a | 89.0 ± 7.8a | 73.0 ± 35.3a |
| Diabetic control | 411.4 ± 35.2bc | 434.4 ± 37.9b | 439.0 ± 35.2b | 456.6 ± 34.4b |
|
| 431.8 ± 81.6b | 442.4 ± 55.7b | 415.8 ± 42.2b | 447.6 ± 30.0b |
|
| 360.2 ± 36.0c | 390.2 ± 57.0b | 426.0 ± 22.7b | 446.3 ± 3.05b |
Different letters between groups on each day indicate a significant difference (P < 0.05), Fisher-LSD test.
Figure 2Hepatic lipid peroxidation assay. (a) Hypercholesterolemic mice treated with C. odorata or J. regia extracts. (b) Diabetic rats treated with C. odorata or J. regia extracts during 10 days. Different letters between groups on each figure indicate a significant difference (P < 0.05), one-way ANOVA; Tx: tyloxapol.
DNA damage according to the comet assay for the assessment of the genotoxicity of J. regia and C. odorata.
| Treatments | Comet class | ||||
|---|---|---|---|---|---|
| Total | 0 | 1 | 2 | 3 | |
|
| |||||
| Negative control | 40.5 ± 21.41a | 77.0 ± 9.38a | 10.7 ± 4.08a | 7.2 ± 5.60a | 5.2 ± 3.54a |
| CPA (50 mg/kg) | 170.2 ± 12.31b | 5.0 ± 2.28b | 39.0 ± 7.01b | 36.8 ± 5.52b | 19.2 ± 3.12b |
|
| 64.0 ± 52.44c | 60.8 ± 25.4a | 20.8 ± 6.83bc | 12.0 ± 11.22c | 6.4 ± 8.29a |
|
| 31.8 ± 8.93a | 73.3 ± 6.56a | 19.8 ± 3.86bc | 5.5 ± 5.24a | 0.3 ± 0.18c |
|
| 58.7 ± 20.83a | 65.5 ± 8.07a | 15.5 ± 5.00a | 13.8 ± 9.97c | 5.2 ± 3.60a |
|
| 109.5 ± 30.48b | 39.2 ± 10.94c | 25.7 ± 4.67c | 21.7 ± 3.26d | 13.5 ± 9.28b |
|
| |||||
| Negative control | 15.0 ± 3.79a | 87.8 ± 3.37a | 9.8 ± 3.54a | 1.8 ± 0.75a | 0.5 ± 0.83a |
| CPA (50 mg/kg) | 96.8 ± 8.93b | 29.5 ± 5.08b | 47.3 ± 7.14c | 20.0 ± 4.56b | 3.2 ± 1.94b |
|
| 9.4 ± 7.53a | 90.8 ± 7.25a | 8.6 ± 6.54a | 0.4 ± 0.89a | 0a |
|
| 12.3 ± 4.17a | 88.8 ± 3.43a | 10.0 ± 2.96a | 1.2 ± 1.16a | 0a |
|
| 11.8 ± 4.40a | 89.2 ± 3.86a | 9.8 ± 3.48a | 1.0 ± 0.89a | 0a |
|
| 29.3 ± 15.88c | 74.7 ± 11.96c | 21.2 ± 8.95b | 3.8 ± 0.86c | 0.2 ± 0.40a |
Mean ± standard error. Different letters between groups in each column correspond to significant differences at 4 and 24 hours. P < 0.5, one-way ANOVA; Fisher LSD, comparing the treatments separately at 4 and 24 hours.
Figure 3Comet assay images in leucocytes of mice (400x). (a) Negative control group, (b) CPA group, (c) extract of J. regia at 200 mg/kg, and (d) extract of C. odorata at 200 mg/kg.